# Intratumoral Dendritic Cell Vaccination Combined With Local Radiotherapy in Patients With Recurrent Lymphoma.

> **NCT00637117** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Baylor Research Institute**

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** Autologous dendritic cells generated using GM-CSF, interferon alpha and LPS

## Key facts

- **NCT ID:** NCT00637117
- **Lead sponsor:** Baylor Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-07
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study never opened and not sure if it ever will.
- **Last updated:** 2017-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00637117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00637117, "Intratumoral Dendritic Cell Vaccination Combined With Local Radiotherapy in Patients With Recurrent Lymphoma.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00637117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*